CervoMed Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRVO research report →
About the company
CervoMed Inc. , a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a.
- CEO
- John J. Alam
- IPO
- 2008
- Employees
- 15
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $32.87M
- P/E
- -1.09
- P/S
- 101.90
- P/B
- 3.10
- EV/EBITDA
- -0.83
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -9642.13%
- Net Margin
- -9311.65%
- ROE
- -136.08%
- ROIC
- -292.99%
- Revenue
- $0 · 0.00%
- Net Income
- $-26,966,367 · -65.53%
- EPS
- $-2.98 · -47.52%
- Op Income
- $-28,294,877
- FCF YoY
- -41.86%
- 52W High
- $13.13
- 52W Low
- $2.13
- 50D MA
- $3.40
- 200D MA
- $5.74
- Beta
- -4.42
- Avg Volume
- 5.48M
Get TickerSpark's AI analysis on CRVO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | BOGER JOSHUA S | buy | 955,414 |
| Jun 11, 26 | BOGER JOSHUA S | buy | 955,414 |
| Jun 11, 26 | BOGER JOSHUA S | buy | 955,414 |
| Jun 8, 26 | ZAVRL FRANK | other | 8,150 |
| Jun 8, 26 | Sabbagh Marwan | other | 8,150 |
| Jun 8, 26 | Quigley David | other | 8,150 |
| Jun 8, 26 | Poulton Jeffrey V. | other | 8,150 |
| Jun 8, 26 | Hollingsworth Jane H | other | 8,150 |
| Jun 8, 26 | Gregoire Sylvie | other | 8,150 |
| Jun 8, 26 | BOGER JOSHUA S | other | 8,150 |
Our CRVO coverage
Recent articles, reports, and earnings notes.
No research on CRVO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRVO report →Similar companies
Peers in the same neighborhood.